Last Updated : February 20, 2015
Details
FilesGeneric Name:
Vedolizumab
Project Status:
Complete
Therapeutic Area:
Ulcerative colitis
Manufacturer:
Takeda Canada Inc.
Call for patient/clinician input open:
Brand Name:
Entyvio
Project Line:
Reimbursement Review
Project Number:
SR0421-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Performance Metric:
Achieved
Submission Type:
Initial
Indications:
Ulcerative Colitis
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation:
Files
Last Updated : February 20, 2015